CompletedNCT01151696
Official study titlePrise en Charge Pharmacologique de l'anxiété et de la Douleur Chez Les Patients Qui Souffrent en Situation d'Urgence Traumatique pré-hospitalière : étude randomisée contrôlée en Double Aveugle
This study has finished and is no longer accepting participants.
In FranceAnxietyMedication studyAges 18+
- Countries
- France
- Sponsor
- University Hospital, Toulouse
CompletedNCT01281527
What is this study about?Researchers studied Paliperidone Palmitate to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18+
- Countries
- France, United Kingdom, Switzerland, + 17 others
- Sponsor
- Janssen-Cilag International NV
UnknownNCT06616337
Official study titleRetrospective Study of the Acceptability and Effectiveness of a Dialectical Behavioral Therapy Group in Patients Suffering From Emotional Dysregulation (Borderline Personality Disorder, Bipolar Disorder and Adult ADHD)
Current recruitment status is unconfirmed.
In FrancePersonality disordersObservational studyAges 18+
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
CompletedNCT01435928
Official study titleA Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18–75
- Countries
- France, United States, Italy, + 4 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT01914393
Official study titleA 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects
This study has finished and is no longer accepting participants.
In FranceSchizophrenia, Bipolarity, ...Medication studyAges 6–17
- Countries
- France, United States, Bulgaria, + 11 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT01911429
What is this study about?Researchers compared Lurasidone 40 mg, Lurasidone 80 mg and placebo to find out how the approaches affected psychotic symptoms in young people with schizophrenia.
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 13–17
- Countries
- France, United States, United Kingdom, + 13 others
- Sponsor
- Sumitomo Pharma America, Inc.
Active Not RecruitingNCT03356028
Official study titlePedopsychiatric and Multidisciplinary Research (Public Health, Psychodynamics, Neuroscience and Human and Social Sciences) Devoted to Children Exposed to the Attack in Nice on July 14, 2016
This study is no longer accepting new participants.
In FrancePTSDBehavioural studyUp to age 18
- Countries
- France
- Sponsor
- Fondation Lenval
CompletedNCT03988218
Official study titlePerception and Representation of Internal Body in Anorexia Nervosa
This study has finished and is no longer accepting participants.
In FranceEating disordersBehavioural studyAges 14+
- Countries
- France
- Sponsor
- Centre Hospitalier Esquirol